Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma

Activation of PTGS2 /NF‐κB signaling pathway enhances radiation resistance of glioma

(2019) Cheng Tan et al.   Cancer Medicine

Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis

(2018) Yuxuan Zhen et al.   JOURNAL OF AUTOIMMUNITY

Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer

(2018) Alvaro Avivar-Valderas et al.   Oncotarget

Prognostic Factors for Survival Outcome of High-Grade Multicentric Glioma

(2018) Tianwei Wang et al.   World Neurosurgery

Replication Protein A Availability During DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells

(2018) François Bélanger et al.   CANCER RESEARCH

Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells

(2018) Daniel M. Foulkes et al.   Science Signaling

A long noncoding RNA MAP3K1-2 promotes proliferation and invasion in gastric cancer

(2018) Lei Wu et al.   OncoTargets and Therapy

TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling

(2018) Zhenlin Hou et al.   Molecular Cancer

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2

(2017) Jia Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

Overcoming therapeutic resistance in glioblastoma: the way forward

(2017) Satoru Osuka et al.   JOURNAL OF CLINICAL INVESTIGATION

EGFR Mutations Compromise Hypoxia-Associated Radiation Resistance through Impaired Replication Fork–Associated DNA Damage Repair

(2017) Mohammad Saki et al.   MOLECULAR CANCER RESEARCH

TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT

(2017) Richard Hill et al.   Nature Communications

TRIB2 contributes to cisplatin resistance in small cell lung cancer

(2017) Yuanxin Liang et al.   Oncotarget

Reciprocal regulation between O-GlcNAcylation and tribbles pseudokinase 2 (TRIB2) maintains transformative phenotypes in liver cancer cells

(2016) Bingjie Yao et al.   CELLULAR SIGNALLING

On-Chip Clonal Analysis of Glioma-Stem-Cell Motility and Therapy Resistance

(2016) Daniel Gallego-Perez et al.   NANO LETTERS

NF-YC in glioma cell proliferation and tumor growth and its role as an independent predictor of patient survival

(2016) Hua Cui et al.   NEUROSCIENCE LETTERS

MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro

(2016) Chun Liu et al.   SpringerPlus

BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53

(2016) Er Nie et al.   Scientific Reports

Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide

(2015) Jonathan L. Tso et al.   Molecular Cancer

Histone H3 Phosphorylation in GBM: a New Rational to Guide the Use of Kinase Inhibitors in anti-GBM Therapy

(2015) Romain Pacaud et al.   Theranostics

Brain tumors in Sweden: Data from a population-based registry 1999–2012

(2014) Thomas Asklund et al.   ACTA ONCOLOGICA

Association ofHelicobacter pyloriinfection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis

(2014) S. Nie et al.   DISEASES OF THE ESOPHAGUS

Compartmentalized self-replication under fast PCR cycling conditions yields Taq DNA polymerase mutants with increased DNA-binding affinity and blood resistance

(2014) Bahram Arezi et al.   Frontiers in Microbiology

TRIB2 Acts Downstream of Wnt/TCF in Liver Cancer Cells to Regulate YAP and C/EBPα Function

(2013) Jiayi Wang et al.   MOLECULAR CELL

Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3

(2013) P. Mao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM

(2011) Y.-W. Kim et al.   NEURO-ONCOLOGY